![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1661061
¹ÙÀδõ ºÎÇüÁ¦ ½ÃÀå º¸°í¼ : Á¦Ç° À¯Çü, ¿ëµµ, Áö¿ªº°(2025-2033³â)Binder Excipients Market Report by Product Type (Cellulosics, Lactose, Polyols, Povidones, Starch and Polysaccharides, Co-Processed Compressible Excipients, and Others), Application (Tablets and Capsules, Solution Based), and Region 2025-2033 |
¼¼°èÀÇ ¹ÙÀδõ ºÎÇüÁ¦ ½ÃÀå ±Ô¸ð´Â 2024³â¿¡ 15¾ï 3,000¸¸ ´Þ·¯¿¡ ´ÞÇß½À´Ï´Ù. ÇâÈÄ IMARC GroupÀº ½ÃÀåÀÌ 2033³â±îÁö 21¾ï 8,000¸¸ ´Þ·¯¿¡ ´ÞÇϸç, 2025-2033³â¿¡ 3.82%ÀÇ ¼ºÀå·ü(CAGR)À» º¸ÀÏ °ÍÀ¸·Î ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. °æ±¸¿ë ÀǾàǰ¿¡ ´ëÇÑ ´ëÁß ¼ö¿ä Áõ°¡, ȯÀÚ Á᫐ Á¦Çü¿¡ ´ëÇÑ °ü½É Áõ°¡, ±¤¹üÀ§ÇÑ Á¶»ç °³¹ß Ȱµ¿ÀÌ ½ÃÀåÀ» ÁÖµµÇÏ´Â ÁÖ¿ä ¿äÀÎÀ¸·Î ÀÛ¿ëÇϰí ÀÖ½À´Ï´Ù.
¹ÙÀδõ ºÎÇüÁ¦´Â ƯÈ÷ °æ±¸¿ë °íü Á¦Á¦¿¡ »ç¿ëµÇ´Â °æ¿ì Á¦¾à Á¦Á¦¿¡ ÇʼöÀûÀÎ ¼ººÐ Áß Çϳª·Î ÀÛ¿ëÇÕ´Ï´Ù. ¹ÙÀδõ´Â Á¤Á¦ ¶Ç´Â ĸ½¶ÀÇ ¾àÈ¿ ¹°Áú ¹× ±âŸ ¿ä¼Ò¸¦ °áÇÕÇÏ¿© ¾ÈÁ¤ÀûÀÌ°í °ü¸®Çϱ⠽¬¿î ÃÖÁ¾ Á¦Ç°À» ¸¸µå´Â µ¥ »ç¿ëµË´Ï´Ù. À̵éÀº Ä£¼ö¼º ºÐÀÚ·Î ¼¿·ê·Î¿À½º À¯µµÃ¼¿Í °°Àº Á¦Á¦ÀÇ ´Ù¸¥ ¼ººÐ°ú °·ÂÇÑ ºÐÀÚ °£ »óÈ£ ÀÛ¿ëÀ» ÀÏÀ¸Å³ ¼ö ÀÖ½À´Ï´Ù. ºÐ¸» È¥ÇÕ¹°ÀÇ ¾ÐÃ༺À» ³ôÀÌ´Â °ÍÀº ¹ÙÀδõ ºÎÇüÁ¦ÀÇ ÁÖ¿ä ¸ñÀû Áß ÇϳªÀ̸ç, Á¤Á¦ ¶Ç´Â ĸ½¶¿¡ °¡´ÉÇÑ ÇÑ ÀÏÁ¤ÇÑ Å©±â¿Í ¸ð¾çÀ» Á¦°øÇÏ¿© ÀϰüµÇ°í ¿¹Ãø °¡´ÉÇÑ ¿ë·®À» º¸ÀåÇÕ´Ï´Ù. ¶ÇÇÑ ºÐ¸» È¥ÇÕ¹°ÀÇ À¯µ¿¼ºÀ» °³¼±ÇÏ¿© Á¤Á¦ ¾ÐÃà ¹× Ä¸½¶ ÃæÀüÀ» ¿ëÀÌÇÏ°Ô ÇÕ´Ï´Ù. ¶ÇÇÑ È°¼º ¼ººÐÀÇ ¹æÃâ Á¦¾î´Â ¹ÙÀδõ ºÎÇüÁ¦ÀÇ ¶Ç ´Ù¸¥ Áß¿äÇÑ ±â´ÉÀ̸ç, ÀǾàǰÀÇ Ä¡·á È¿°ú¸¦ À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ¹ÙÀδõ ºÎÇüÁ¦¿¡´Â õ¿¬ °íºÐÀÚ, ÇÕ¼º °íºÐÀÚ, ´ç·ù, ÀüºÐ µî ¿©·¯ À¯ÇüÀÌ ÀÖ½À´Ï´Ù.
ȯÀÚµé »çÀÌ¿¡¼ °æ±¸¿ë ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ´Â °ÍÀÌ ¼¼°è ½ÃÀåÀ» Å©°Ô °ßÀÎÇϰí ÀÖ½À´Ï´Ù. ÀÌ´Â Åõ¿©°¡ ½±°í Æí¸®Çϸç Á¤È®ÇÑ Åõ¾àÀÌ °¡´ÉÇÏ´Ù´Â ÀåÁ¡ÀÌ ½ÃÀåÀ» ÁÖµµÇϰí Àֱ⠶§¹®ÀÔ´Ï´Ù. ¶ÇÇÑ ¸¹Àº Á¦¾àȸ»çµéÀÌ »õ·Î¿î Á¤Á¦ ¹× ĸ½¶ °³¹ß¿¡ ¸¹Àº ÅõÀÚ¸¦ Çϰí ÀÖÀ¸¸ç, ÀÌ´Â ¹ÙÀδõ ºÎÇüÁ¦¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² ȯÀÚÀÇ º¹¾à ¼øÀÀµµ ¹× º¹¾à °èȹ Áؼö¸¦ °³¼±Çϱâ À§ÇØ ¸¸µé¾îÁø ȯÀÚ Á᫐ Á¦Á¦¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö°í ÀÖ´Â °Íµµ ½ÃÀåÀ» Å©°Ô Áö¿øÇϰí ÀÖ½À´Ï´Ù. ÀÌ¿Í ÇÔ²² Ư¼ö ¹ÙÀδõ ºÎÇüÁ¦°¡ ÇÊ¿äÇÑ ¼¹æÇü Á¤Á¦ ¹× ĸ½¶°ú °°Àº »õ·Î¿î ¾à¹°Àü´Þ ½Ã½ºÅÛÀÇ °³¹ßµµ ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖ½À´Ï´Ù. À̿ʹ º°µµ·Î, °Ç° º¸Á¶ ½ÄǰÀÎ ´ºÆ®¸®½´Æ¼Äÿ¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå¿¡ ±àÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¿À¸®Áö³Î ÀǾàǰÀÇ Æ¯Çã ¸¸·á·Î ÀÎÇÑ Á¦³×¸¯ ÀǾàǰ¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡µµ ½ÃÀå ¼ºÀå¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ °øµ¿ °¡°ø ºÎÇüÁ¦¿Í °°Àº »õ·Î¿î ºÎÇüÁ¦ÀÇ °³¹ßÀº ½ÃÀå Àü¸ÁÀ» ¹à°Ô Çϰí ÀÖ½À´Ï´Ù. ½ÃÀåÀ» ÃËÁøÇÏ´Â ´Ù¸¥ ¿äÀÎÀ¸·Î´Â Çõ½ÅÀûÀÎ Ä¡·á¹ý¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡¿Í ÇコÄÉ¾î ºÐ¾ßÀÇ Áö¼ÓÀûÀÎ °³¼± µîÀÌ ÀÖ½À´Ï´Ù.
The global binder excipients market size reached USD 1.53 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 2.18 Billion by 2033, exhibiting a growth rate (CAGR) of 3.82% during 2025-2033. The increasing demand for oral medications among the masses, the growing focus on patient-centric formulations, and extensive research and development activities represent some of the key factors driving the market.
Binder excipients act as one of the essential components in pharmaceutical formulations, especially when utilized in solid oral dose forms. They are employed to bind the pharmaceutical active substances and other elements of a tablet or capsule, resulting in a stable and manageable final product. They are hydrophilic molecules that can generate potent intermolecular interactions with the other components of the formulation, such as cellulose derivatives. Enhancing the powder mixture's compressibility is one of the primary purposes of binder excipients, which provide tablets or capsules with the constant size and shape possible, guaranteeing a consistent and predictable dose. Additionally, they aid in enhancing the powder mixture's flow characteristics, making it simpler to compress tablets or fill capsules. They also aid in controlling the release of the active ingredient release is another crucial function of binder excipients as well as they help in maintaining the therapeutical effect of the medicinal drugs, which is crucial for medications to have a limited therapeutic window or are absorbed only in certain parts of the body. There are several types of binder excipients available, including natural and synthetic polymers, sugars, and starches
The escalating demand for oral medicines among the patients majorly drives the global market. This is due to their several benefits, such as easy administration, convenience, and accurate dosing, which are driving the market. In addition, numerous pharmaceutical companies are investing heavily in the development of new tablet and capsule formulations, which is propelling the demand for binder excipients. Along with this, the growing focus on patient-centric formulations, which are created to improve patient compliance and adherence to a medication regimen, is significantly supporting the market. In line with this, the development of novel drug delivery systems, such as modified-release tablets and capsules, requiring specialized binder excipients is also providing a thrust to the demand. Apart from this, the growing demand for nutraceuticals, which are dietary supplements that offer health benefits, is influencing the market favorably. In addition, the rising demand for generic drugs on account of the increasing number of patents expiring on branded drugs is contributing to the market. Furthermore, the development of novel excipients, such as co-processed excipients, is creating a positive market outlook. Some of the other factors driving the market include the rising demand for innovative therapies and continual improvements in the healthcare sector.